| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd9e80066072812aee2a23109e395af4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71b74b22719bf6c53643d1c7ffd88002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00924da5ad2b0e91dcd35bab32529f78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3b719e471d3c60a6effcec64bd9e3f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e875e52d970ad2f4c8fb91743970758 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-592
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-592 |
| filingDate |
2004-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e42d86136edcae57620c722d062f17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed28206948793272e2a2db72154ff84a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_546c5329123b45005b1be3a6c06fd6cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e16cf574696055615c3358f7483cc84 |
| publicationDate |
2005-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005051396-A3 |
| titleOfInvention |
Methods for reducing body fat using vitamin d compounds |
| abstract |
A treatment for obesity and overweight comprises administering a vitamin D analog. The analog effectively inhibits an increase in body fat to animals at risk and decreases the basal fat content of animals. The treatment has a positive effect on the lean body component such that while there is an overall decrease in body weight, there is also a decrease in percent body fat. This decrease can be proportionally greater than the overall decrease in body weight. In addition, the treatment has a positive effect on bone turnover and osteogeneses making the vitamin D analog a beneficial treatment for the symptoms of menopause. Various exemplary embodiments of the treatment use the 2-alkylidene derivatives of vitamin D3, such as the 2-alkyliden-19-nor derivatives in both the R and S configurations at carbon-20. |
| priorityDate |
2003-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |